DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2vdrld/2014) has announced the addition of the "2014 Opportunities in the US Transfusion Diagnostic Testing Market" report to their offering.

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in the US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years

Blood Typing and Grouping Tests:

• ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests:

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT

Sales and Market Share Analysis:

• Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product

Competitive Assessments:

• Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis:

• Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and key suppliers.
• Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: Blood Centers, Hospitals, Commercial/Private Laboratories

Current and Emerging Products:

• Analysis of current and emerging blood typing, grouping and infectious disease screening tests
• Review of automated and semi-automated

Technology Review:

• Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market.
• Comprehensive lists of companies developing or marketing new technologies and products, by test

Strategic Recommendations:

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

For more information visit http://www.researchandmarkets.com/research/2vdrld/2014